Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'

(MedPage Today) -- Progression-free survival reasonably predicts overall survival in advanced prostate cancer and could bring new therapies to patients about 2 years faster if used as the primary endpoint in clinical studies. (University College...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news